Omada Health

Omada is virtual care that adapts to real life: Prediabetes, Diabetes, Heart Health, GLP-1s, Muscle & Joint Pain. Established in 2011.

[Omada Health @omadahealth]

Omada just performed one of the largest GLP-1 patient surveys of its kind. Stigma remains a barrier to treatment, patients want more time with providers, and dynamics around initiating GLP-1 conversations are shifting. Read our survey findings. https://t.co/n4zD6mGHTc

[Omada Health @omadahealth]

Our new 12-week study looked at how body composition changes when people lose weight on GLP-1s. We analyzed who lost body fat while preserving muscle mass, and how they felt and functioned––with Omada’s support versus without it. Read the whitepaper now. https://t.co/wFCMWibfXR

[Nasdaq Exchange @NasdaqExchange]

Congratulations to @omadahealth on one year as a #NasdaqListed company! Relive this unforgettable bell-ringing moment of Co-Founder & CEO @seanduffy with his five-year-old daughter, Aletta. Here's to many more milestones ahead.

[Omada Health @omadahealth]

One year post-IPO: greater scale, accelerated financial performance and 2M+ members served. What hasn’t changed is our focus on better outcomes, lower costs, and earned trust. We’re here to bend the curve of chronic disease, one day at a time. #CelebrateOMDA

[Omada Health @omadahealth]

3,000+ GLP-1 patients just told us what’s working, what’s breaking, and what they wish their employers understood. Read the results of our 2026 GLP-1 patient survey: https://t.co/n4zD6mGHTc

[Omada Health @omadahealth]

In our latest 12-week study on body composition and GLP-1s, the group who received Omada’s support reported greater improvements in lifestyle change, physical function, and confidence in their ability to lose weight. Read the full white paper now. https://t.co/wFCMWibfXR

[Omada Health @omadahealth]

Members don’t feel accountable to a prescription or an app; they feel accountable to people. Omada’s GLP‑1 care model is—and will remain—human‑led, with AI used to scale that connection, not replace it.

Learn more: https://t.co/tZymW2g6Ke

[Omada Health @omadahealth]

High cholesterol rarely shows up alone—it appears alongside obesity, hypertension, & diabetes, quietly stacking cardiovascular risk. Omada for Cholesterol treats it as part of a full system, with between‑visit support that ties labs to daily behavior.
https://t.co/LtSLpPm3UP

[Omada Health @omadahealth]

The GLP‑1 market is complex: multiple indications, fragmented access, shifting benefit designs. Employers need help with navigating the complicated space.

Omada offers GLP‑1 companion care, prescribing, and flexible options for employers. Learn more: https://t.co/tZymW2g6Ke

[Omada Health @omadahealth]

It’s about more than weight loss – when taking GLP-1s. Members should consider how changes in muscle mass affect their long‑term health. Our latest whitepaper unpacks it. https://t.co/EyMkyE2jQ8

[Omada Health @omadahealth]

See how Omada’s care team helps people take real‑life obstacles and turn them into small steps forward.

Our care teams are supported by AI to help deliver tangible outcomes across key help metrics. Learn more: https://t.co/sqTuv2Op9z

[Omada Health @omadahealth]

The market is moving faster than real world results, Omada is focused on evidence. OmadaSpark, built with @AWSAI & @AIatMeta, gives safe, context-aware nutrition guidance in real time. https://t.co/asHSMaQpaS

[Omada Health @omadahealth]

Most employers think managing GLP-1 coverage and cost is important, but finding a financially sustainable path can be difficult. Not anymore. Introducing Omada’s GLP-1 Flex Care, a solution that empowers employers with a benefits strategy for every budget:https://t.co/6xdqiYEz8j

[Omada Health @omadahealth]

$OMDA Q1 2026:
📈 Revenue +42% YoY to $78M
👥 1M+ Total Members (+51% YoY)
📉 GAAP net loss narrowed to $3M; positive Adjusted EBITDA (non-GAAP) in our highest-cost quarter

Reach, enrollment, engagement, efficiency each delivered for a milestone quarter. https://t.co/ifsFHpdY88

[Omada Health @omadahealth]

Most employers think managing GLP-1 coverage and cost is important, but finding a financially sustainable path can be difficult. Introducing Omada’s GLP-1 Flex Care, a solution that empowers employers with a benefits strategy for every budget. https://t.co/6xdqiYEz8j

[Omada Health @omadahealth]

For employers, the real GLP‑1 question isn’t just “What do they cost?”—it’s “What do we get for what we spend?” Omada acts as a GLP‑1 value maximizer, wrapping coaching and behavior change around meds to improve persistence and long‑term outcomes. https://t.co/RO7e4fhT1D

[Omada Health @omadahealth]

Benefits leaders know that a flexible strategy for GLP-1s isn’t a nice-to-have; it’s a must in this rapidly expanding and costly landscape. Omada’s GLP-1 Flex Care helps employers widen access and improve long-term outcomes. Coming in 2026. Learn more: https://t.co/6xdqiYEz8j

[Omada Health @omadahealth]

What is the best GLP-1 benefits strategy? A flexible one. Omada’s GLP-1 Flex Care gives employers more options when it comes to increasing access to these medications, without sacrificing outcomes. https://t.co/0cUsFXFYkI

[Omada Health @omadahealth]

We are now available through @OptumRx's Weight Engage, making Omada available for employers to purchase through all 3 largest PBMs,

OptumRx clients can now offer members our GLP-1 medication care paired with behavior change.

Learn more: https://t.co/dFwjoSDtcU

[Omada Health @omadahealth]

If your GLP‑1 strategy stops at “pounds lost,” you’re missing value. Omada helps members lose more of the right weight, and improve body composition and function. https://t.co/bvG1jHplwO